As of 2026-03-09, the EV/EBITDA ratio of Redx Pharma PLC (REDX.L) is -1.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. REDX.L's latest enterprise value is 38.49 mil GBP. REDX.L's TTM EBITDA according to its financial statements is -30.02 mil GBP. Dividing these 2 quantities gives us the above REDX.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 6.5x | 5.1x |
| Forward P/E multiples | 4.5x - 8.0x | 6.2x |
| Fair Price | (52.40) - (75.09) | (65.54) |
| Upside | -449.3% - -600.6% | -536.9% |
| Date | EV/EBITDA |